Skip to content
HowShorted

MYRIAD GENETICS INC short interest in 2022

In 2022, MYRIAD GENETICS INC's disclosed short interest ran from 4.80% of shares outstanding on 14 Jan 2022 to 4.38% on 30 Dec 2022, a change of -0.42 percentage points. The year's high was 5.41% on 15 Jul 2022 and its low 4.18% on 14 Apr 2022, averaging 4.76% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.63 days on 15 Feb 2022. Full history: MYRIAD GENETICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MYRIAD GENETICS INC in 2022

2022 in figures

Start of year
4.80% (14 Jan 2022)
End of year
4.38% (30 Dec 2022)
Change
-0.42 pp
High
5.41% (15 Jul 2022)
Low
4.18% (14 Apr 2022)
Average
4.76%
Highest days to cover
10.63 (15 Feb 2022)
SEC filings marked
9

Every report in 2022

MYRIAD GENETICS INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.80%6.53results (8-K)
31 Jan 20225.39%7.39
15 Feb 20225.18%10.63
28 Feb 20225.19%8.55results (8-K), 10-K filed
15 Mar 20225.05%6.12
31 Mar 20224.52%6.50
14 Apr 20224.18%6.99
29 Apr 20224.21%7.32
13 May 20224.80%5.81results (8-K), 10-Q filed
31 May 20224.56%7.43
15 Jun 20224.56%6.37
30 Jun 20224.38%5.89
15 Jul 20225.41%9.22
29 Jul 20224.52%5.88
15 Aug 20225.21%7.36results (8-K), 10-Q filed
31 Aug 20224.80%8.75
15 Sep 20224.87%8.77
30 Sep 20224.69%7.28
14 Oct 20224.73%7.82
31 Oct 20224.75%8.13
15 Nov 20225.01%4.57results (8-K), 10-Q filed
30 Nov 20224.21%7.00
15 Dec 20224.78%6.28
30 Dec 20224.38%2.56

See also: MYRIAD GENETICS INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.